HTA25 Factors Including Real-World Evidence (RWE) That Play a Role in the HTA Recommendation of Oncology Drug Submissions Based on Phase II and/or Single Arm Trial Data
Jun 1, 2023, 00:00
10.1016/j.jval.2023.03.1454
https://www.valueinhealthjournal.com/article/S1098-3015(23)01554-1/fulltext
Title :
HTA25 Factors Including Real-World Evidence (RWE) That Play a Role in the HTA Recommendation of Oncology Drug Submissions Based on Phase II and/or Single Arm Trial Data
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)01554-1&doi=10.1016/j.jval.2023.03.1454
First page :
Section Title :
Open access? :
No
Section Order :
10854